BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 30783323)

  • 1. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.
    Malik J; Karan M; Dogra R
    Pharm Biol; 2017 Dec; 55(1):980-990. PubMed ID: 28164735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
    Mehrotra A; Sood A; Sandhir R
    Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain.
    Kumar P; Kalonia H; Kumar A
    Drug Chem Toxicol; 2010 Oct; 33(4):377-92. PubMed ID: 20550427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S; Ramachandran S; Krishnamurthy P
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
    Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
    Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S; Thangarajan S
    Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
    Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
    Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
    Kumar P; Kalonia H; Kumar A
    Behav Pharmacol; 2010 May; 21(3):217-30. PubMed ID: 20480544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats.
    Thakur T; Sharma S; Kumar K; Deshmukh R; Sharma PL
    Eur J Pharmacol; 2013 Aug; 714(1-3):515-21. PubMed ID: 23831390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.